Cargando…
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
Genetic polymorphisms in the genes that encode drug-metabolizing enzymes are implicated in the inter-individual variability in the pharmacokinetics and pharmaco-dynamics of antiepileptic drugs (AEDs). However, the clinical impact of these polymorphisms on AED therapy still remains controversial. The...
Autores principales: | Saruwatari, Junji, Ishitsu, Takateru, Nakagawa, Kazuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033946/ https://www.ncbi.nlm.nih.gov/pubmed/27713373 http://dx.doi.org/10.3390/ph3082709 |
Ejemplares similares
-
Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population
por: Zhao, Weixuan, et al.
Publicado: (2022) -
Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
por: Ogusu, Naoki, et al.
Publicado: (2014) -
Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
por: Tanamachi, Yukiko, et al.
Publicado: (2015) -
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
por: Nakashima, Hiroo, et al.
Publicado: (2015) -
Antiepileptic drugs and bone metabolism
por: Valsamis, Helen A, et al.
Publicado: (2006)